Latest Articles
Endometriosis Breakthroughs: New Treatments and Research - News-Medical.Net
Endometriosis Breakthroughs: New Treatments and Research News-Medical.Net
Published: March 21, 2025, 10:06 a.m.
Mounjaro could be next breakthrough pain relief treatment for endometriosis - Surrey Live
Mounjaro could be next breakthrough pain relief treatment for endometriosis Surrey Live
Published: March 21, 2025, 10 a.m.
Diagnosis and treatment of endometriosis | Healthwatch 16 - WNEP Scranton/Wilkes-Barre
Diagnosis and treatment of endometriosis | Healthwatch 16 WNEP Scranton/Wilkes-Barre
Published: March 20, 2025, 9:23 p.m.
Endometriosis sufferers experiencing long delays for treatment, report finds, as SA government vows change - ABC News
Endometriosis sufferers experiencing long delays for treatment, report finds, as SA government vows change ABC News
Published: March 20, 2025, 7:01 p.m.
Endometrial Cell Atlas in PCOS Could Improve Treatment - Mirage News
Endometrial Cell Atlas in PCOS Could Improve Treatment Mirage News
Published: March 20, 2025, 10:02 a.m.
Eye care crisis: Alarming truth behind India's treatment gap - Healthcare Radius
Eye care crisis: Alarming truth behind India's treatment gap Healthcare Radius
Published: March 20, 2025, 9:06 a.m.
NICE Approves First-Ever Daily Pill for Endometriosis Treatment - geneonline
NICE Approves First-Ever Daily Pill for Endometriosis Treatment geneonline
Published: March 20, 2025, 9:03 a.m.
Landmark endometriosis report promises major overhaul in treatment and awareness in South Australia - Glam Adelaide
Landmark endometriosis report promises major overhaul in treatment and awareness in South Australia Glam Adelaide
Published: March 20, 2025, 1:34 a.m.
Rachel spends $400 a month on a disease affecting 830,000 Aussies. Treatment just got cheaper for some - 9News
Rachel spends $400 a month on a disease affecting 830,000 Aussies. Treatment just got cheaper for some 9News
Published: March 19, 2025, 10:55 p.m.
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy The Malaysian …
Published: March 19, 2025, 10:53 p.m.
Link copied to clipboard!